Nurse Practitioner, Primary Care · Durham, NC
NPI
1235500893
Since 2015
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Duke Cancer Ctr, 20 Duke Medicine Circle, Box 3233
Durham, NC, 27710
Phone (919) 681-5257
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
230 services
Medicare patients, 2024
68
Average age 72
Drug cost, 2024
$521K
577 prescriptions
Company payments, 2025
$2,856
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paula S Kennedy-Newton was code 99214 (office e&m - established), 81 times for 48 patients. In total Paula S Kennedy-Newton billed 230 services in 3 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 81 | 48 | $51.69 | $4,187 |
| 99215 Office E&M - Established | Facility | 77 | 33 | $83.08 | $6,397 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 72 | 36 | $10.34 | $744 |
By year: 2022 $11K for 169 services; 2023 $9,361 for 138 services; 2024 $11K for 230 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paula S Kennedy-Newton prescribed most often to Medicare patients was Oxycodone Hcl, with 53 prescriptions and refills. In total Paula S Kennedy-Newton wrote 577 Medicare prescriptions that cost $521K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 53 | 53 | 21 | $1,321 |
| Potassium Chloride Generic | 38 | 48 | Under 11 | $1,495 |
| Xermelo Telotristat Etiprate | 31 | 31 | Under 11 | $285K |
| Ondansetron Hcl Generic | 31 | 37 | 12 | $401 |
| Pantoprazole Sodium Generic | 23 | 39 | Under 11 | $149 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 21 | 21 | Under 11 | $513 |
| Prochlorperazine Maleate Generic | 18 | 22 | 12 | $459 |
| Eliquis Apixaban | 17 | 21 | Under 11 | $12K |
| Olanzapine Generic | 17 | 25 | Under 11 | $160 |
| Ondansetron Odt Ondansetron | 17 | 17 | 11 | $483 |
| Creon Lipase/Protease/Amylase | 16 | 22 | Under 11 | $69K |
| Tramadol Hcl Generic | 16 | 16 | Under 11 | $96.53 |
| Xarelto Rivaroxaban | 15 | 25 | Under 11 | $14K |
| Gabapentin Generic | 15 | 15 | Under 11 | $118 |
| Octreotide Acetate Generic | 15 | 15 | Under 11 | $6,481 |
Brand drugs: 130 claims; generic drugs: 447 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula S Kennedy-Newton $2,856 ($2,856 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exelixis Inc. with $2,828.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.